Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mundipharma is a global network of independent associated pharmaceutical companies with a strong focus on pain management, respiratory health, oncology, and biosimilars. The company is well-known for its portfolio of analgesic medications and has expanded significantly into the biosimilars market through strategic partnerships. Mundipharma provides a range of commercialized products including Targin for pain and various monoclonal antibodies for oncology and inflammatory conditions. Headquartered in Cambridge, UK, the organization operates across Europe, Asia-Pacific, Latin America, and the Middle East. Its business model emphasizes the acquisition and licensing of innovative treatments to address unmet medical needs in specialty care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mundipharma Farmacêutica.